Back to Treatments

Treatment

Dasatinib

1
Conditions
142
Trials
15K
Participants
60%
Average Safety

Condition Evidence

Chronic myeloid leukemia

142 trials · 15K participants

92% effectiveness · 60% safety
Dasatinib | DFDA